167 related articles for article (PubMed ID: 38485425)
1. Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.
Hartner AM; Li X; Echeverria-Londono S; Roth J; Abbas K; Auzenbergs M; de Villiers MJ; Ferrari MJ; Fraser K; Fu H; Hallett T; Hinsley W; Jit M; Karachaliou A; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Minh QT; Vynnycky E; Winter AK; Burrows H; Chen C; Clapham HE; Deshpande A; Hauryski S; Huber J; Jean K; Kim C; Kim JH; Koh J; Lopman BA; Pitzer VE; Tam Y; Lambach P; Sim SY; Woodruff K; Ferguson NM; Trotter CL; Gaythorpe KAM
Lancet Glob Health; 2024 Apr; 12(4):e563-e571. PubMed ID: 38485425
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries.
Gaythorpe KA; Abbas K; Huber J; Karachaliou A; Thakkar N; Woodruff K; Li X; Echeverria-Londono S; ; Ferrari M; Jackson ML; McCarthy K; Perkins TA; Trotter C; Jit M
Elife; 2021 Jun; 10():. PubMed ID: 34165077
[TBL] [Abstract][Full Text] [Related]
3. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
Abbas K; Procter SR; van Zandvoort K; Clark A; Funk S; Mengistu T; Hogan D; Dansereau E; Jit M; Flasche S;
Lancet Glob Health; 2020 Oct; 8(10):e1264-e1272. PubMed ID: 32687792
[TBL] [Abstract][Full Text] [Related]
4. Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world.
Toor J; Echeverria-Londono S; Li X; Abbas K; Carter ED; Clapham HE; Clark A; de Villiers MJ; Eilertson K; Ferrari M; Gamkrelidze I; Hallett TB; Hinsley WR; Hogan D; Huber JH; Jackson ML; Jean K; Jit M; Karachaliou A; Klepac P; Kraay A; Lessler J; Li X; Lopman BA; Mengistu T; Metcalf CJE; Moore SM; Nayagam S; Papadopoulos T; Perkins TA; Portnoy A; Razavi H; Razavi-Shearer D; Resch S; Sanderson C; Sweet S; Tam Y; Tanvir H; Tran Minh Q; Trotter CL; Truelove SA; Vynnycky E; Walker N; Winter A; Woodruff K; Ferguson NM; Gaythorpe KA
Elife; 2021 Jul; 10():. PubMed ID: 34253291
[TBL] [Abstract][Full Text] [Related]
5. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study.
Li X; Mukandavire C; Cucunubá ZM; Echeverria Londono S; Abbas K; Clapham HE; Jit M; Johnson HL; Papadopoulos T; Vynnycky E; Brisson M; Carter ED; Clark A; de Villiers MJ; Eilertson K; Ferrari MJ; Gamkrelidze I; Gaythorpe KAM; Grassly NC; Hallett TB; Hinsley W; Jackson ML; Jean K; Karachaliou A; Klepac P; Lessler J; Li X; Moore SM; Nayagam S; Nguyen DM; Razavi H; Razavi-Shearer D; Resch S; Sanderson C; Sweet S; Sy S; Tam Y; Tanvir H; Tran QM; Trotter CL; Truelove S; van Zandvoort K; Verguet S; Walker N; Winter A; Woodruff K; Ferguson NM; Garske T;
Lancet; 2021 Jan; 397(10272):398-408. PubMed ID: 33516338
[TBL] [Abstract][Full Text] [Related]
6. Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
Causey K; Fullman N; Sorensen RJD; Galles NC; Zheng P; Aravkin A; Danovaro-Holliday MC; Martinez-Piedra R; Sodha SV; Velandia-González MP; Gacic-Dobo M; Castro E; He J; Schipp M; Deen A; Hay SI; Lim SS; Mosser JF
Lancet; 2021 Aug; 398(10299):522-534. PubMed ID: 34273292
[TBL] [Abstract][Full Text] [Related]
7. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
[TBL] [Abstract][Full Text] [Related]
8. The estimated mortality impact of vaccinations forecast to be administered during 2011-2020 in 73 countries supported by the GAVI Alliance.
Lee LA; Franzel L; Atwell J; Datta SD; Friberg IK; Goldie SJ; Reef SE; Schwalbe N; Simons E; Strebel PM; Sweet S; Suraratdecha C; Tam Y; Vynnycky E; Walker N; Walker DG; Hansen PM
Vaccine; 2013 Apr; 31 Suppl 2():B61-72. PubMed ID: 23598494
[TBL] [Abstract][Full Text] [Related]
9. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
10. Potential population-level effectiveness of one-dose HPV vaccination in low-income and middle-income countries: a mathematical modelling analysis.
Bénard É; Drolet M; Laprise JF; Gingras G; Jit M; Boily MC; Bloem P; Brisson M
Lancet Public Health; 2023 Oct; 8(10):e788-e799. PubMed ID: 37777288
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.
Toor J; Li X; Jit M; Trotter CL; Echeverria-Londono S; Hartner AM; Roth J; Portnoy A; Abbas K; Ferguson NM; Am Gaythorpe K
Vaccine; 2022 Jul; 40(31):4142-4149. PubMed ID: 35672179
[TBL] [Abstract][Full Text] [Related]
12. Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis.
Bénard É; Drolet M; Laprise JF; Jit M; Prem K; Boily MC; Brisson M
Lancet Glob Health; 2023 Jan; 11(1):e48-e58. PubMed ID: 36521952
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study.
Bilcke J; Antillón M; Pieters Z; Kuylen E; Abboud L; Neuzil KM; Pollard AJ; Paltiel AD; Pitzer VE
Lancet Infect Dis; 2019 Jul; 19(7):728-739. PubMed ID: 31130329
[TBL] [Abstract][Full Text] [Related]
14. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
15. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories.
Shet A; Carr K; Danovaro-Holliday MC; Sodha SV; Prosperi C; Wunderlich J; Wonodi C; Reynolds HW; Mirza I; Gacic-Dobo M; O'Brien KL; Lindstrand A
Lancet Glob Health; 2022 Feb; 10(2):e186-e194. PubMed ID: 34951973
[TBL] [Abstract][Full Text] [Related]
16. Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study.
Abbas K; Yoo KJ; Prem K; Jit M
EClinicalMedicine; 2024 Apr; 70():102524. PubMed ID: 38685933
[TBL] [Abstract][Full Text] [Related]
17. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis.
Bruni L; Diaz M; Barrionuevo-Rosas L; Herrero R; Bray F; Bosch FX; de Sanjosé S; Castellsagué X
Lancet Glob Health; 2016 Jul; 4(7):e453-63. PubMed ID: 27340003
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of measles and rubella vaccination programmes for disease elimination: a modelling study.
Winter AK; Lambert B; Klein D; Klepac P; Papadopoulos T; Truelove S; Burgess C; Santos H; Knapp JK; Reef SE; Kayembe LK; Shendale S; Kretsinger K; Lessler J; Vynnycky E; McCarthy K; Ferrari M; Jit M
Lancet Glob Health; 2022 Oct; 10(10):e1412-e1422. PubMed ID: 36113527
[TBL] [Abstract][Full Text] [Related]
19. Estimating total spending by source of funding on routine and supplementary immunisation activities in low-income and middle-income countries, 2000-17: a financial modelling study.
Ikilezi G; Micah AE; Bachmeier SD; Cogswell IE; Maddison ER; Stutzman HN; Tsakalos G; Brenzel L; Dieleman JL
Lancet; 2021 Nov; 398(10314):1875-1893. PubMed ID: 34742369
[TBL] [Abstract][Full Text] [Related]
20. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study.
Abbas KM; van Zandvoort K; Brisson M; Jit M
Lancet Glob Health; 2020 Apr; 8(4):e536-e544. PubMed ID: 32105613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
